Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adar Yaacov

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Medicine|December 30, 2025
Bronchoalveolar Lavage in Immunocompetent Patients with Pneumonia: A Retrospective Cohort Study Shows No Survival BenefitAlon Pomerantz, Adar Yaacov, Adam Goldman, et al.
Computers in Biology and Medicine|December 19, 2024
Graph convolution networks model identifies and quantifies gene and cancer specific transcriptome signatures of cancer driver eventsGil Ben Cohen, Adar Yaacov, Yishai Ben Zvi, et al.
Plos One|June 21, 2022
High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencingLyora A Cohen-Aharonov, Annie Rebibo-Sabbah, Adar Yaacov, et al.
Scientific Reports|September 20, 2024
Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemiaAdar Yaacov, Gregory Lazarian, Tatjana Pandzic, et al.
Cancer Research Communications|June 26, 2026
A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancerAlberto A Gabizon, Hadar Goldvaser, Adar Yaacov, et al.
Cancers|May 4, 2026
The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)Roni Gillis, Tamar Zahavi, Nir Peled, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Medicine|December 30, 2025
Bronchoalveolar Lavage in Immunocompetent Patients with Pneumonia: A Retrospective Cohort Study Shows No Survival BenefitAlon Pomerantz, Adar Yaacov, Adam Goldman, et al.
Computers in Biology and Medicine|December 19, 2024
Graph convolution networks model identifies and quantifies gene and cancer specific transcriptome signatures of cancer driver eventsGil Ben Cohen, Adar Yaacov, Yishai Ben Zvi, et al.
Plos One|June 21, 2022
High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencingLyora A Cohen-Aharonov, Annie Rebibo-Sabbah, Adar Yaacov, et al.
Scientific Reports|September 20, 2024
Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemiaAdar Yaacov, Gregory Lazarian, Tatjana Pandzic, et al.
Cancer Research Communications|June 26, 2026
A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancerAlberto A Gabizon, Hadar Goldvaser, Adar Yaacov, et al.
Cancers|May 4, 2026
The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)Roni Gillis, Tamar Zahavi, Nir Peled, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Pageof 2